Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 2/20 | 0.60 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.60 |
| ▸ | F12 | P00748 | 1/20 | 0.60 |
| ▸ | NCF1 | P14598 | 1/20 | 0.60 |
| ▸ | NOS3 | P29474 | 1/20 | 0.60 |
| ▸ | NOS1 | P29475 | 1/20 | 0.60 |
| ▸ | NOS2 | P35228 | 1/20 | 0.60 |
| ▸ | BACE1 | P56817 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.53 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29923403 | 1.00 | PLAU (0.60) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL30522769 | 0.97 | PLAU (0.58) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL13978866 | 0.90 | PLAU (0.56) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL12223316 | 0.90 | PLAU (0.56) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL12112873 | 0.88 | MAPT (0.58) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL4500979 | 0.87 | KDM4E (0.53) | PLAUCYP2A6F12NCF1NOS3 | |
| Dipyridyl SCHEMBL4596384 | 0.87 | KDM4E (0.56) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL50715 | 0.86 | KDM4E (0.66) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL29398625 | 0.86 | KDM4E (0.66) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL24663020 | 0.84 | MAPT (0.50) | PLAUCYP2A6F12NCF1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4526357-A1 | FLUORINATED POLYMERIZATION CATALYSTS AND METHODS OF MAKING AND USING THE SAME | University of Houston System (US) | 2025-03-26 | — | — | EP | claimed |
| CN-119143668-A | Iron complex based on biisoquinoline and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118725264-A | Fused heterocyclic polymer containing bisisoquinoline structure and preparation method and application thereof | 深圳大学 | 2024-10-01 | — | — | CN | claimed |
| US-11976153-B2 | Fluorinated polymerization catalysts and methods of making and using the same | UNIVERSITY OF HOUSTON SYSTEM (US) | 2024-05-07 | — | — | US | claimed |
| US-20230374171-A1 | FLUORINATED POLYMERIZATION CATALYSTS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF HOUSTON SYSTEM | 2023-11-23 | — | — | US | claimed |
| WO-2023225216-A1 | FLUORINATED POLYMERIZATION CATALYSTS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-11-23 | — | — | WO | claimed |
| CN-116874421-A | Method for synthesizing 1,1' -biisoquinoline derivative from 2, 2-dimethyl-4, 5-diaryl-2H-imidazole | 桂林理工大学 | 2023-10-13 | — | — | CN | claimed |
| CN-116621777-A | Method for synthesizing 1,1' -biisoquinoline oxynitride | 桂林理工大学 | 2023-08-22 | — | — | CN | claimed |
| US-20190140182-A1 | DIBROMO-DIIODO-DIPOLYCYCLIC COMPOUND AND ELECTRON ACCEPTOR MOLECULES DERIVED THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-05-09 | — | — | US | claimed |
| US-10211402-B2 | Dibromo-diiodo-dipolycyclic compound and electron acceptor molecules derived therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2019-02-19 | — | — | US | claimed |
| EP-0355575-B1 | Method of preventing polymer scale formation | SHINETSU CHEMICAL CO (JP) | 1994-11-02 | — | — | EP | claimed |
| EP-0601113-A1 | RARE EARTH MACROCYCLIC COMPLEXES AND USE THEREOF FOR REDUCTION OF DISTURBANCES IN AN ASSAY USING FLUORESCENCE. | CIS BIO INT (FR) | 1994-06-15 | — | — | EP | claimed |
| US-5298220-A | Forming a coating of a solution containing anioic and cationic dyes and water insoluble organonitrogen compound, drying | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1994-03-29 | — | — | US | claimed |
| EP-0180492-B1 | MACROPOLYCYCLIC COMPLEXES OF RARE EARTH METALS AND APPLICATION AS FLUORESCENT LABELS | CIS BIO INTERNATIONAL (FR) | 1993-06-02 | — | — | EP | claimed |
| US-5196164-A | During addition polymerization, wall coating of anionic dye and cationic dye and organonitrogen compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1993-03-23 | — | — | US | claimed |
| WO-1993005049-A1 | RARE EARTH MACROCYCLIC COMPLEXES AND USE THEREOF FOR REDUCTION OF DISTURBANCES IN AN ASSAY USING FLUORESCENCE | CIS BIO INTERNATIONAL (FR) | 1993-03-18 | — | — | WO | claimed |
| EP-0479843-A1 | BIPYRIDYLES, PROCESS FOR MAKING THEM AND THEIR USE | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1992-04-15 | — | — | EP | claimed |
| WO-1991000276-A1 | BIPYRIDYLES, PROCESS FOR MAKING THEM AND THEIR USE | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1991-01-10 | — | — | WO | claimed |
| EP-0355575-A2 | Method of preventing polymer scale formation | Shin-Etsu Chemical Co., Ltd. (JP) | 1990-02-28 | — | — | EP | claimed |
| EP-0180492-A1 | Macropolycyclic complexes of rare earth metals and application as fluorescent labels | CIS BIO INTERNATIONAL (FR) | 1986-05-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10211402-B2 | Dibromo-diiodo-dipolycyclic compound and electron acceptor molecules derived therefrom | WEE2, WEE1, WASF2 | PLAU 4663/4885CYP2A6 1755/4885F12 4603/4885 |
| US-20190140182-A1 | DIBROMO-DIIODO-DIPOLYCYCLIC COMPOUND AND ELECTRON ACCEPTOR MOLECULES DERIVED THEREFROM | WEE2, WEE1, WASF2 | PLAU 4663/4885CYP2A6 1755/4885F12 4603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.